Investment Summary

Eight Roads Invests In Qixiangyun

On September 14, 2022, private equity firm Eight Roads invested in software company Qixiangyun

Investment Highlights
  • This is Eight Roads’ 49th transaction in the Software sector.
  • This is Eight Roads’ 65th transaction in China.

Investment Summary
Date 2022-09-14
Target Qixiangyun
Sector Software
Investor(s) Eight Roads
Deal Type Venture

Target

Qixiangyun

Beijing, China
Qixiangyun is a developer of an enterprise finance and taxation information system. Qixiangyun mainly based on an open platform architecture, with an intelligent financial and tax report accounting engine as the core, it provides APIs and configurable functional modules that can be integrated by any enterprise software system. Qixiangyun is based in Beijing, China.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Eight Roads

Investor

Category Private Equity Firm
Founded 1969
Size Small
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

DEAL STATS #
Overall 295 of 298
Sector (Software) 49 of 49
Type (Venture) 266 of 269
Country (China) 65 of 65
Year (2022) 22 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-10 Jade Bird Display

Shanghai, China

Jade Bird Display is a MicroLED display manufacturer. Jade Bird Display was founded in 2015 and is based in Shanghai, China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-27 Elucidata

Cambridge, Massachusetts, United States

Elucidata is a life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data. Elucidata was founded in 2015 and is based in Cambridge, Massachusetts.

Buy -
Mergr

Product

Company

Legal